
1356-Next-Generation ADCs: Path Toward Precision Medicine
This collection of research excerpts explores the current landscape and future trajectory of antibody-drug conjugates (ADCs) in oncology. The sources highlight the critical evolution of precision medicine, emphasizing how next-generation therapies must address challenges like antigen heterogeneity and complex resistance mechanisms. By integrating multidimensional biomarkers and advanced imaging techniques, researchers aim to refine patient selection and improve the therapeutic window. The text also details the shift toward rational drug combinations and the development of bispecific ADCs to…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.